APA (7th ed.) Citation

Sandmann, T., & Wick, W. (2015). Patients with proneural glioblastoma may derive overall survival benefit from the addition of bevacizumab to first-line radiotherapy and temozolomide: Retrospective analysis of the AVAglio trial. Journal of clinical oncology, 33(25), . https://doi.org/10.1200/JCO.2015.61.5005

Chicago Style (17th ed.) Citation

Sandmann, Thomas, and Wolfgang Wick. "Patients with Proneural Glioblastoma May Derive Overall Survival Benefit from the Addition of Bevacizumab to First-line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial." Journal of Clinical Oncology 33, no. 25 (2015). https://doi.org/10.1200/JCO.2015.61.5005.

MLA (9th ed.) Citation

Sandmann, Thomas, and Wolfgang Wick. "Patients with Proneural Glioblastoma May Derive Overall Survival Benefit from the Addition of Bevacizumab to First-line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial." Journal of Clinical Oncology, vol. 33, no. 25, 2015, https://doi.org/10.1200/JCO.2015.61.5005.